EP1912630A4 - COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN - Google Patents

COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN

Info

Publication number
EP1912630A4
EP1912630A4 EP06788416A EP06788416A EP1912630A4 EP 1912630 A4 EP1912630 A4 EP 1912630A4 EP 06788416 A EP06788416 A EP 06788416A EP 06788416 A EP06788416 A EP 06788416A EP 1912630 A4 EP1912630 A4 EP 1912630A4
Authority
EP
European Patent Office
Prior art keywords
compositions
post
reduction
methods
operative pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06788416A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1912630A2 (en
Inventor
Richard L Kronenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORTHOCON Inc
Original Assignee
ORTHOCON Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/224,650 external-priority patent/US7955616B2/en
Application filed by ORTHOCON Inc filed Critical ORTHOCON Inc
Publication of EP1912630A2 publication Critical patent/EP1912630A2/en
Publication of EP1912630A4 publication Critical patent/EP1912630A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP06788416A 2005-07-25 2006-07-25 COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN Withdrawn EP1912630A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US70222605P 2005-07-25 2005-07-25
US11/224,650 US7955616B2 (en) 2003-09-23 2005-09-12 Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US75830006P 2006-01-12 2006-01-12
PCT/US2006/028823 WO2007014210A2 (en) 2005-07-25 2006-07-25 Compositions and methods for the reduction of post-operative pain

Publications (2)

Publication Number Publication Date
EP1912630A2 EP1912630A2 (en) 2008-04-23
EP1912630A4 true EP1912630A4 (en) 2012-10-03

Family

ID=37683910

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06788416A Withdrawn EP1912630A4 (en) 2005-07-25 2006-07-25 COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN

Country Status (8)

Country Link
EP (1) EP1912630A4 (ko)
JP (1) JP2009502928A (ko)
KR (1) KR20080055782A (ko)
CN (1) CN101484145A (ko)
AU (2) AU2006272663C1 (ko)
CA (1) CA2616384A1 (ko)
NZ (1) NZ563557A (ko)
WO (1) WO2007014210A2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856283A (zh) 2003-09-23 2006-11-01 奥斯治疗有限公司 生物可吸收的油灰样止血植入体
US8105628B2 (en) 2003-09-23 2012-01-31 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US7955616B2 (en) 2003-09-23 2011-06-07 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US8603528B2 (en) 2004-09-16 2013-12-10 Abyrx, Inc. Compositions and method for the reduction of post-operative pain
US20110027331A1 (en) * 2009-07-29 2011-02-03 Warsaw Orthopedic, Inc. An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
CA3107935A1 (en) * 2011-10-28 2013-05-02 Baxter International Inc. Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture
KR101852718B1 (ko) * 2017-04-04 2018-05-18 주식회사 제네웰 외과수술 후 절개부위 통증 감소를 위한 키트
CN112138203B (zh) * 2019-06-26 2022-11-08 陕西佰傲再生医学有限公司 骨止血材料

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US20020090398A1 (en) * 1999-11-16 2002-07-11 Atrix Laboratories, Inc. Biodegradable polymer composition
US20030093157A1 (en) * 2001-06-29 2003-05-15 Casares Crisoforo Peralta Biodegradable injectable implants and related methods of manufacture and use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439420A (en) * 1982-11-16 1984-03-27 Ethicon, Inc. Absorbable hemostatic composition
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US6890894B2 (en) * 2000-02-22 2005-05-10 The Procter & Gamble Company Fatty acids, soaps surfactant systems, and consumer products based thereon
US7112587B2 (en) * 2001-09-21 2006-09-26 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
US8105628B2 (en) * 2003-09-23 2012-01-31 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US20020090398A1 (en) * 1999-11-16 2002-07-11 Atrix Laboratories, Inc. Biodegradable polymer composition
US20030093157A1 (en) * 2001-06-29 2003-05-15 Casares Crisoforo Peralta Biodegradable injectable implants and related methods of manufacture and use

Also Published As

Publication number Publication date
EP1912630A2 (en) 2008-04-23
CN101484145A (zh) 2009-07-15
WO2007014210A3 (en) 2007-10-18
AU2006272663B2 (en) 2010-10-28
AU2011200355A1 (en) 2011-02-17
WO2007014210A2 (en) 2007-02-01
CA2616384A1 (en) 2007-02-01
JP2009502928A (ja) 2009-01-29
AU2006272663C1 (en) 2011-08-11
AU2006272663A1 (en) 2007-02-01
NZ563557A (en) 2011-04-29
KR20080055782A (ko) 2008-06-19

Similar Documents

Publication Publication Date Title
EP1879659A4 (en) REIZARING COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
IL189795A0 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
EP1959929A4 (en) COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
EP1940423A4 (en) TISSUE ENGINEERING METHOD AND COMPOSITIONS
EP1853295A4 (en) METHOD AND COMPOSITIONS FOR TREATING GASTROINTESTINAL DISEASES
EP1940441A4 (en) COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
IL181543A0 (en) Dendrimer based compositions and methods of using the same
IL196465A0 (en) Compositions and methods for the treatment of mucositis
IL186963A0 (en) Methods and compositions for treating pain
IL183709A0 (en) Compositions and methods for treating conditions of the nail unit
IL191072A0 (en) Therapeutic compositions and methods
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
ZA200808431B (en) Fungicidal compositions and methods of using the same
EP2049151A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
ZA200800448B (en) Methods and compositions for the prevention and treatment of inflammatory disease
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
IL191537A0 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP1720893A4 (en) COMPOSITIONS AND METHODS FOR SYSTEMIC TREATMENT OF ARTHRITIS
IL187405A0 (en) Methods and compositions for the treatment of pain
EP1912630A4 (en) COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN
EP1720563A4 (en) METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION
EP1933805A4 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080222

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120903

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 13/00 20060101ALI20120828BHEP

Ipc: A61K 31/00 20060101ALI20120828BHEP

Ipc: A61K 9/22 20060101AFI20120828BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130201